EUCTR2004-000651-42-SE
Active, not recruiting
Not Applicable
Efficacy and Safety of Intraprostatic Injection of Mepivacaine Adrenaline prior to ProstaLund Feedback Treatment in Patients with Symptomatic Benign Prostatic Hyperplasia (BPH).
ProstaLundOperations AB0 sites48 target enrollmentJune 23, 2004
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Kan mikrovågsbehandling av godartad prostataförstoring förbättras med avsende på energiåtgång och patientkomfort genom att ge en lokal injektion av bedövningsmedel(carbocain adernalin) innan behandling?
- Sponsor
- ProstaLundOperations AB
- Enrollment
- 48
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.män 45 år eller äldre
- •2\.Symptomatisk BPH
- •3 Prostata volym åtminstone 30 ml och prostata längd åtminstone 35 mm
- •4\. Informerat samtycke
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\. Medicinska och/eller psykologiska orsaker att inte tolerera studieproceduren.
- •2\. Tidigare genomgången mikrovågsterapi,TUR\-P, laser prostatektomi eller någon kirurgisk behandling av prostata.
- •3\. Tidigare strålning av bäcken eller tidigare genomgången kirurgiskt ingrepp i bäcken.
- •4\. Tidigare uretrastriktur,blåshalskontraktur eller blås patologi.
- •5\. Tecken på pågående prostatit
- •6\. Misstanke om prostatacancer(patienter med PSA density \>0,15 g/l/g skall genomgå biopsi för att utesluta malignitet)
- •7\. Misstanke om blåscancer
- •8\. Stor median lob
- •9\. Känd neurologisk sjukdom(ex multiple scleros,Parkinson eller stroke) eller misstanke på svinkter abnormalitet och/eller neurogen blåsa.
- •10\. Symtomatisk UVI vid tidpunkt för behandlingen.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
A clinical trial to study the effects of mumps-measles-rubella vaccine in improving patients with multiple warts in skiHealth Condition 1: null- Multiple Cutaneous WartsCTRI/2017/10/010021Dr Prof Shyam Sundar Chaudhary
Active, not recruiting
Phase 1
Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled studyModerate-to-severe COVID-19 pneumoniaMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-003614-13-ITImmuneMed Inc.105
Active, not recruiting
Phase 1
Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients with Iron Deficiency AnemiaEUCTR2019-003821-70-PLAmerican Regent, Inc.10
Not yet recruiting
Phase 4
Efficacy and Saftey of Intravenous Versus Oral Iron Therapy in Postpartum Anemia - A Randomised Controlled TrialCTRI/2020/02/023125Department of Obstetrics And Gynecology
Not yet recruiting
Phase 2
Clinical study on the intravesical instillation of heparin, lidocain and bicarbonate for the patients with interstitial cystitisJPRN-UMIN000006387niversity of Tokushima30